Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135,288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study.
Zeng X, Liu J, Liu X, Wu L, Liu Y, Liao X, Liu H, Hu J, Lu X, Chen L, Xu J, Jiang Z, Lu FA, Wu H, Li Y, Wang Q, Zhu J; HLX01-RA03 Investigators. Zeng X, et al. Among authors: liu j, liu y, liu x, liu h. Arthritis Res Ther. 2022 Jun 10;24(1):136. doi: 10.1186/s13075-022-02821-x. Arthritis Res Ther. 2022. PMID: 35689239 Free PMC article. Clinical Trial.
Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis.
Jin S, Li M, Fang Y, Li Q, Liu J, Duan X, Liu Y, Wu R, Shi X, Wang Y, Jiang Z, Wang Y, Yu C, Wang Q, Tian X, Zhao Y, Zeng X; CREDIT Co-authors. Jin S, et al. Among authors: liu j, liu y. Arthritis Res Ther. 2017 Nov 15;19(1):251. doi: 10.1186/s13075-017-1457-z. Arthritis Res Ther. 2017. PMID: 29141688 Free PMC article.
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study.
Liu Y, Liu S, Liu L, Gong X, Liu J, Sun L, Liu X, Wu L, Chen L, Wang L, Luo L, Lin J, Tie N, Jiang Z, Wu J, Lu F, Sun H, Li X, Yang N, Chai K, Wei H, Da Z, Zhao C, Dai L, Wang Y, Shi G, Zhang Z, Song H, Guo Q, Liu YC, Li Z. Liu Y, et al. Among authors: liu j, liu x, liu l, liu s, liu yc. Rheumatol Ther. 2022 Feb;9(1):175-189. doi: 10.1007/s40744-021-00396-8. Epub 2021 Nov 22. Rheumatol Ther. 2022. PMID: 34806155 Free PMC article.
China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees.
Gong X, Liu WX, Li D, Peng QW, Xia CM, Chang T, Guan JZ, Song MG, Zhang FY, Tang XP, Liu Y, Liu J, Peng JY, He DY, Huang QC, Gao ML, Yu JP, Liu W, Zhang JY, Zhu YL, Hou XJ, Wang HD, Fang YF, Wang Y, Su Y, Tian XP, Su X, Meng QL, Wen SY, Wang B, Li ZG, Liu J, Jiang H, Hu Y, Li HL, Wei SF, Zhu WH, Lyu AP, Zhang C, Jiang Q; CERTAIN Group. Gong X, et al. Among authors: liu wx, liu j, liu y, liu w. Phytomedicine. 2022 Sep;104:154236. doi: 10.1016/j.phymed.2022.154236. Epub 2022 Jun 14. Phytomedicine. 2022. PMID: 35797864
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study.
Leng X, Lin W, Liu S, Kanik K, Wang C, Wan W, Jiang Z, Liu Y, Liu S, Zhang Z, Zhang Z, Xu J, Tan W, Hu J, Li J, Liu J, Gunay LM, Dina O, Kinch C, Zeng X. Leng X, et al. Among authors: liu j, liu y, liu s. RMD Open. 2023 Jan;9(1):e002559. doi: 10.1136/rmdopen-2022-002559. RMD Open. 2023. PMID: 36720560 Free PMC article. Clinical Trial.
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study.
Yang Y, Li J, Liu J, Liu L, Wang Y, Hu J, Li Z, Gu J, Zhang X, Xiao Z, Zheng J, Liu L, Li Z, Wei JC. Yang Y, et al. Among authors: liu j, liu l. Lancet Reg Health West Pac. 2023 Oct 18;42:100925. doi: 10.1016/j.lanwpc.2023.100925. eCollection 2024 Jan. Lancet Reg Health West Pac. 2023. PMID: 38357391 Free PMC article.
135,288 results
You have reached the last available page of results. Please see the User Guide for more information.